Public Health Archives - Page 8 of 35 - Boston Life Sciences Times

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

December 17, 2025

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

December 16, 2025

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

December 13, 2025

THIS WEEK'S STORIES

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

December 11, 2025

Cosette Pharmaceuticals Terminates Agreement to Acquire Mayne Pharma

December 12, 2025

CellTivity Scientific Receives CE Registration for Van Gogh Microscopy System, Expanding Diagnostic Use Across Europe

December 17, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Federal Health Leaders Join Food Allergy Fund Forum to Chart Future of Research and Innovation

Dexcom Reveals Global Diabetes Advocates for World Diabetes Day

Brighton Marine Launches $100,000 Basic-Needs Initiative to Support Boston Veterans

New Research: GLP-1 Therapies Could Reduce U.S. Mortality by 3.5% Over the Next Two Decades

ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues

Most Read

eClinicalWorks, Sunoh.ai Help AssociatesMD Boost Productivity and Expand Access to Care

Element Care Appoints Andrew Zamansky as Chief Financial Officer

CellTivity Scientific Receives CE Registration for Van Gogh Microscopy System, Expanding Diagnostic Use Across Europe

Mobile Heartbeat Announces New Voice Enhancements and Resiliency Features for Clinical Communication Platform

EDITOR PICKS

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

THIS WEEK'S STORIES

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

Cosette Pharmaceuticals Terminates Agreement to Acquire Mayne Pharma

CellTivity Scientific Receives CE Registration for Van Gogh Microscopy System, Expanding Diagnostic Use Across Europe

POPULAR CATEGORY

ABOUT US

FOLLOW US